Shop

Home » Shop » Fluorecare COMBO 4in1 test | SARS-CoV-2 | Influenza A+B | RSV | 25 pieces

Fluorecare COMBO 4in1 test | SARS-CoV-2 | Influenza A+B | RSV | 25 pieces

229,99 PLN per package (25 pieces)

Work efficiently, order profitably!
Place wholesale orders at info@bisaf.pl

Product designed for professional use.

In stock

Product description

Fluorecare COMBO 4-in-1 Test Influenza A+B / COVID-19 / RSV

This is a rapid in vitro diagnostic test designed for the qualitative detection of SARS-CoV-2 antigens, Influenza type A (including subtype H1N1) and B antigens, as well as RSV virus using the colloidal gold method. It can be used as an aid in the diagnosis of infections caused by the mentioned viruses in individuals displaying characteristic symptoms or in asymptomatic individuals (in the presence of epidemiological reasons justifying suspicion of infection). The test can be performed using throat, nasal, or nasopharyngeal swab samples under in vitro conditions.

1 swab = 4 results

The high accuracy of this test allows for reliable results obtained in just 12 minutes!

Product intended for professional use.

Properties

sample material: nasal swab, throat swab, or nasopharyngeal swab
painless collection of the test sample
high product quality
quick result in as little as 12 minutes!
bulk packaging of 25 units
product designed for professional use

Test specification

accuracy of SARS-CoV-2: 92.9%
accuracy of influenza A: 91.8%
accuracy of influenza B: 92.7%
accuracy of RSV: 96.97%

The package contains

25 test cassettes
25 single-pack sample processing solutions
25 dropper cap covers
25 sterile swabs
25 extraction tubes
instruction manual

Test Application

this test kit is used for simultaneous qualitative detection and differentiation of the new Coronavirus (SARS-CoV-2 antigen), Influenza A virus, Influenza B virus antigen, and/or RSV antigen in population-based throat, nasal, and nasopharyngeal swab samples under in vitro conditions
the test is intended for screening, making it an excellent tool for primary care physicians and general practitioners who can quickly confirm or rule out infections caused by one of the four most common respiratory viruses